Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
J Am Acad Psychiatry Law
; 45(4): 472-477, 2017 12.
Article
in En
| MEDLINE
| ID: mdl-29282239
ABSTRACT
Opioid addiction is a chronic, relapsing disorder associated with criminality, unemployment, infectious diseases, and legal problems. Such addictions are typically over-represented in correctional populations. Inmates with untreated opioid addiction often relapse shortly after release into the community, thereby increasing the risk of overdose, serious illnesses (HIV, hepatitis C) and psychosocial problems (e.g., crimes, recidivism, and reincarceration). There are three U.S. Food and Drug Administration-approved medications for the treatment of opioid use disorder methadone, buprenorphine, and naltrexone. Opioid replacement therapies (ORTs) are associated with significant benefits, including reducing the incidences of HIV, criminality, and opioid-related mortality. However, most opioid-dependent Americans who are incarcerated are forced to discontinue ORT upon prison entry. This article offers a rationale for providing ORT to addicted prisoners while incarcerated and providing appointments with outpatient providers for continued treatment.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prisons
/
Prisoners
/
Opiate Substitution Treatment
/
Methadone
/
Narcotic Antagonists
/
Opioid-Related Disorders
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
J Am Acad Psychiatry Law
Journal subject:
JURISPRUDENCIA
/
PSIQUIATRIA
Year:
2017
Document type:
Article